Rockefeller Capital Management L.P. Passage Bio, Inc. Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$12.44 - $19.45 $94,195 - $147,275	-7,572 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$16.24 - $29.83 $2,777 - $5,100	-171 Reduced 2.21%	7,572 $132,000
Q3 2020 Nov 13, 2020	BUY	$12.39 - $26.15 $39,833 - $84,072	3,215 Added 71.0%	7,743 $101,000
Q2 2020 Aug 12, 2020	BUY	$14.59 - $36.07 $66,063 - $163,324	4,528 New	4,528 $124,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.